Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm
- Status
- COMPLETED
- Phase
- PHASE2
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
- Status
- RECRUITING
- Phase
- NA
Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Cardioprotection in AML
- Status
- RECRUITING
- Phase
- PHASE2
Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
- Status
- RECRUITING
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
- Status
- RECRUITING
- Phase
- PHASE1
2157GCCC:Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Dx AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse.
- Status
- UNKNOWN
- Phase
- N/A
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients
- Status
- UNKNOWN
- Phase
- NA
KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Accelerated Dose Schedule of Cytarabine Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) in Complete Remission
- Status
- TERMINATED
- Phase
- PHASE2
Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML
- Status
- RECRUITING
- Phase
- PHASE2